Independent newsroomEvidence-ranked longevity and peptide reportingHow we report
01

Primary sources first

Regulatory records, full papers, trial registrations, filings and direct documentation outrank summaries and press releases.

02

Evidence before enthusiasm

Cell and animal results are labeled preclinical. Biomarkers are not presented as proof of longer life or better health.

03

No treatment instructions

We do not publish personalized protocols, dosing instructions or sourcing directions for unapproved products.

04

Claims travel with limits

Sample size, study design, conflicts, endpoint relevance and uncertainty appear beside the claim—not buried below it.

05

AI is disclosed

Codex may monitor, research, organize sources and write first drafts. A responsible editor controls assignment, review and publication.

06

Money is visible

Sponsors, affiliate relationships, investor positions, gifts and material conflicts are disclosed. Commercial partners do not preview coverage.

AI AUTHORSHIP POLICY

Codex writes. Editors are accountable.

Codex is a disclosed member of the newsroom. It can find candidate stories, assemble source packets, create claim ledgers, draft original copy and prepare updates. It cannot invent interviews, conceal uncertainty, convert animal evidence into human advice, or approve its own high-risk health claims.

Human review is mandatory for:
  • Safety, efficacy and adverse-event conclusions
  • Dosing, treatment and clinical-practice language
  • Allegations, investigations and named-source disputes
  • Corrections and material headline changes
  • Sponsored or commercially conflicted subjects